List of insiders holdings for Kadmon Holdings Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Former 10% owner | 2021-02-16 15:50:52 | 16,240,747 0 | 16,240,747 | Form 13G |
| Loeb Daniel S Third Point LLC 10% Owner | 2021-05-28 17:04:26 | 7,601,115 0 | 7,601,115 | Form 13G |
| Kadmon I LLC 10% Owner | 2017-01-25 16:41:02 | 5,450,273 0 | 5,450,273 | Form 4 |
| Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 2021-02-12 16:30:40 | 4,283,014 0 | 4,283,014 | Form 13G |
| GOLDENTREE ASSET MANAGEMENT LP GoldenTree Asset Management LLC Tananbaum Steven A. Gaffney Treacy 10% Owner | 2018-06-18 16:44:53 | 3,631,681 0 | 3,631,681 | Form 13D |
| GOLDENTREE ASSET MANAGEMENT LP GoldenTree Asset Management LLC Tananbaum Steven A. 10% Owner | 2018-06-18 16:44:53 | 3,631,681 0 | 3,631,681 | Form 13D |
| Poukalov Konstantin Executive Vice President, CFO | 2017-12-12 16:08:09 | 205,000 0 | 205,000 | Form 4 |
| Boardman D. Dixon Director | 2019-05-16 16:56:51 | 198,079 0 | 198,079 | Form 4 |
| Schwartz Bart M Director | 2018-07-30 17:07:26 | 126,668 0 | 126,668 | Form 4 |
| Darder Charles Principle Accounting Officer | 2017-12-12 16:09:18 | 125,000 0 | 125,000 | Form 4 |
| Gordon Steven N. Exec VP, GC, Chief Admin, Comp | 2019-06-14 16:18:25 | 102,501 0 | 102,501 | Form 4 |
| Cohen Lawrence Kenneth Exec. VP, Business Develop. | 2016-12-16 20:16:05 | 100,000 0 | 100,000 | Form 4 |
| Wiviott Susan Director | 2018-07-30 17:09:34 | 66,925 0 | 66,925 | Form 4 |
| WITTE LARRY Exec. VP, Research & Develop. | 2016-07-26 18:32:41 | 53,036 0 | 53,036 | Form 3 |
| Zhu Zhenping Executive VP Biologics | 2016-07-26 18:38:11 | 47,312 0 | 47,312 | Form 3 |
| Forbes Alexandria Director | 2017-06-30 18:45:58 | 25,000 0 | 25,000 | Form 4 |
| SHENK THOMAS E Director | 2017-06-30 18:54:27 | 25,000 0 | 25,000 | Form 4 |
| Heyman Eva exec VP, Chief Commercial Offi | 2016-07-26 18:30:26 | 22,620 0 | 22,620 | Form 3 |
| Zan Shengda Director | 2016-12-16 20:24:32 | 3077 0 | 3077 | Form 4 |
| Cohen Andrew B Director | 2016-12-16 20:15:01 | 3077 0 | 3077 | Form 4 |
| Waksal Harlan President, CEO | 2021-11-09 17:42:11 | 0 0 | 0 | Form 4 |
| Flowers Cynthia Louise Director | 2021-11-09 17:41:38 | 0 0 | 0 | Form 4 |
| Ryan John L EVP, Chief Medical Officer | 2021-11-09 17:41:04 | 0 0 | 0 | Form 4 |
| Kirsch Arthur S Director | 2021-11-09 17:40:30 | 0 0 | 0 | Form 4 |
| Moss Gregory S. EVP, Gen. Coun. / CCO. | 2021-11-09 17:39:40 | 0 0 | 0 | Form 4 |
| Miller-Rich Nancy Director | 2021-11-09 17:38:51 | 0 0 | 0 | Form 4 |
| Meehan Steven EVP, Chief Financial Officer | 2021-11-09 17:38:11 | 0 0 | 0 | Form 4 |
| Cohen David E Director | 2021-11-09 17:37:34 | 0 0 | 0 | Form 4 |
| Konidaris Tasos Director | 2021-11-09 17:36:52 | 0 0 | 0 | Form 4 |
| Carver Kyle SVP, CAO, Controller | 2021-11-09 17:36:16 | 0 0 | 0 | Form 4 |
| Bauer Eugene Director | 2021-11-09 17:35:33 | 0 0 | 0 | Form 4 |